Cargando…

Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients

Hepatocellular carcinoma (HCC) is the commonest primary tumor of the liver. Chronic HCV infection is the leading cause of end-stage liver disease, HCC and liver-related death in Egypt. Single nucleotide polymorphisms (SNPs) in microRNAs were reported to increase susceptibility to tumorigenesis; affe...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohamed Fteah, Asmaa, Ismail Ahmed, Asmaa, Mosaad, Nehad Ahmed, Mohamed Hassan1, Mona, Mahmoud, Sherif Hamdy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062993/
https://www.ncbi.nlm.nih.gov/pubmed/31759375
http://dx.doi.org/10.31557/APJCP.2019.20.11.3479
_version_ 1783504620657573888
author Mohamed Fteah, Asmaa
Ismail Ahmed, Asmaa
Mosaad, Nehad Ahmed
Mohamed Hassan1, Mona
Mahmoud, Sherif Hamdy
author_facet Mohamed Fteah, Asmaa
Ismail Ahmed, Asmaa
Mosaad, Nehad Ahmed
Mohamed Hassan1, Mona
Mahmoud, Sherif Hamdy
author_sort Mohamed Fteah, Asmaa
collection PubMed
description Hepatocellular carcinoma (HCC) is the commonest primary tumor of the liver. Chronic HCV infection is the leading cause of end-stage liver disease, HCC and liver-related death in Egypt. Single nucleotide polymorphisms (SNPs) in microRNAs were reported to increase susceptibility to tumorigenesis; affect prognosis and as promising biomarkers in virus-host interactions. This study was conducted to investigate the role of genetic variants of miR-196a2 (rs 11614913) C>T and miR-499 (rs 3746444) A>G in the development of cirrhosis and HCC in Egyptian HCV infected patients. Genotyping of the candidate SNPs was performed by Real Time PCR in 75 HCV-related HCC patients, 75 cirrhotic patients on top of HCV and 75 healthy controls. There was significant difference in miR-499 (rs3746444) genotypes frequency between the three studied groups as the GG genotype was significantly lower in HCC cases than other groups (P = 0.009) while the combined miR-499 (AA+AG) genotypes were significantly higher in HCC cases than other groups (P = 0.005). Also a significant difference was found in miR-499 genotypes frequency when compared between HCC and cirrhosis groups as the GG genotype was significantly lower in HCC cases than cirrhosis group (P = 0.006) while the combined miR-499 (AA+AG) genotypes were significantly higher in HCC cases than in cirrhosis group (P = 0.003) [OR (95% CI) = 0.131 (0.028-0.601)]. The frequency of the G allele was significantly lower in HCC than other groups (P = 0.024) and significantly lower in HCC than normal group (P = 0.006) [OR (95%CI) = 0.501 (0.304-0.825)]. For miR-196a2 (rs11614913) C>T polymorphisms, no significant association was found with HCC risk. Our study concluded that the G allele of miR-499 is associated with lower risk of HCV related HCC development. No significant association of miR-196a2 (rs 11614913), genotypes or alleles with risk for HCC development, could be detected.
format Online
Article
Text
id pubmed-7062993
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-70629932020-03-17 Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients Mohamed Fteah, Asmaa Ismail Ahmed, Asmaa Mosaad, Nehad Ahmed Mohamed Hassan1, Mona Mahmoud, Sherif Hamdy Asian Pac J Cancer Prev Research Article Hepatocellular carcinoma (HCC) is the commonest primary tumor of the liver. Chronic HCV infection is the leading cause of end-stage liver disease, HCC and liver-related death in Egypt. Single nucleotide polymorphisms (SNPs) in microRNAs were reported to increase susceptibility to tumorigenesis; affect prognosis and as promising biomarkers in virus-host interactions. This study was conducted to investigate the role of genetic variants of miR-196a2 (rs 11614913) C>T and miR-499 (rs 3746444) A>G in the development of cirrhosis and HCC in Egyptian HCV infected patients. Genotyping of the candidate SNPs was performed by Real Time PCR in 75 HCV-related HCC patients, 75 cirrhotic patients on top of HCV and 75 healthy controls. There was significant difference in miR-499 (rs3746444) genotypes frequency between the three studied groups as the GG genotype was significantly lower in HCC cases than other groups (P = 0.009) while the combined miR-499 (AA+AG) genotypes were significantly higher in HCC cases than other groups (P = 0.005). Also a significant difference was found in miR-499 genotypes frequency when compared between HCC and cirrhosis groups as the GG genotype was significantly lower in HCC cases than cirrhosis group (P = 0.006) while the combined miR-499 (AA+AG) genotypes were significantly higher in HCC cases than in cirrhosis group (P = 0.003) [OR (95% CI) = 0.131 (0.028-0.601)]. The frequency of the G allele was significantly lower in HCC than other groups (P = 0.024) and significantly lower in HCC than normal group (P = 0.006) [OR (95%CI) = 0.501 (0.304-0.825)]. For miR-196a2 (rs11614913) C>T polymorphisms, no significant association was found with HCC risk. Our study concluded that the G allele of miR-499 is associated with lower risk of HCV related HCC development. No significant association of miR-196a2 (rs 11614913), genotypes or alleles with risk for HCC development, could be detected. West Asia Organization for Cancer Prevention 2019 /pmc/articles/PMC7062993/ /pubmed/31759375 http://dx.doi.org/10.31557/APJCP.2019.20.11.3479 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Mohamed Fteah, Asmaa
Ismail Ahmed, Asmaa
Mosaad, Nehad Ahmed
Mohamed Hassan1, Mona
Mahmoud, Sherif Hamdy
Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients
title Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients
title_full Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients
title_fullStr Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients
title_full_unstemmed Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients
title_short Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients
title_sort association of microrna 196a and 499 polymorphisms with development of cirrhosis and hepatocellular carcinoma post-hcv infection in egyptian patients
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062993/
https://www.ncbi.nlm.nih.gov/pubmed/31759375
http://dx.doi.org/10.31557/APJCP.2019.20.11.3479
work_keys_str_mv AT mohamedfteahasmaa associationofmicrorna196aand499polymorphismswithdevelopmentofcirrhosisandhepatocellularcarcinomaposthcvinfectioninegyptianpatients
AT ismailahmedasmaa associationofmicrorna196aand499polymorphismswithdevelopmentofcirrhosisandhepatocellularcarcinomaposthcvinfectioninegyptianpatients
AT mosaadnehadahmed associationofmicrorna196aand499polymorphismswithdevelopmentofcirrhosisandhepatocellularcarcinomaposthcvinfectioninegyptianpatients
AT mohamedhassan1mona associationofmicrorna196aand499polymorphismswithdevelopmentofcirrhosisandhepatocellularcarcinomaposthcvinfectioninegyptianpatients
AT mahmoudsherifhamdy associationofmicrorna196aand499polymorphismswithdevelopmentofcirrhosisandhepatocellularcarcinomaposthcvinfectioninegyptianpatients